HIGHLIGHTS
- who: Ibrahim Tawhari and colleagues from the University of Bologna, Italy have published the research: Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients, in the Journal: (JOURNAL)
- what: The study evaluated the impact of early conversion of CNIs at 3 months to Bela in a steroid-free maintenance immunosuppressive therapy following induction with Alemtuzumab.
- how: The data showed that conversion to Bela + low-dose Tac (targeting a goal tacrolimus trough level u22645 ng/mL) is an effective steroidfree maintenance immunosuppressive regimen and was associated with a +8.81 ml . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.